Primary Site >> Biliary tract Cancer
Gene >> TP53
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates. PMID: 1310637 |
Ref: Undifferentiated spindle cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and flow cytometric study of 11 cases. PMID: 8276377 Ref: Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. PMID: 8280380 Ref: The expression of p53 antigen in primary malignant epithelial tumors of the liver: an immunohistochemical study. PMID: 8393124 Ref: Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations. PMID: 8475992 |
Ref: An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. PMID: 7520348 Ref: Methods in pathology. p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections. PMID: 8008749 Ref: [An early carcinoma of the gallbladder with atypical epithelium ( a report of a case with elevated p53 expression)]. PMID: 8018902 Ref: Mutation of the p53 gene in gallbladder cancer. PMID: 8073440 |
Ref: Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology. PMID: 7557145 Ref: p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater. PMID: 7567135 Ref: p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. PMID: 7657282 Ref: Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases. PMID: 7698709 Ref: Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. PMID: 7780959 Ref: Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. PMID: 7796400 Ref: p53 protein accumulation in tumors of the ampulla of Vater. PMID: 8630891 |
Ref: p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. PMID: 8617479 Ref: K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. PMID: 8630951 Ref: p53 protein expression in extrahepatic bile duct cancer. PMID: 8711933 Ref: Ampullary somatostatinoma in a patient with von Recklinghausen's disease. PMID: 8726843 Ref: Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. PMID: 8740842 Ref: p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions. PMID: 8799388 Ref: p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis. PMID: 8801209 Ref: Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens (bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas. PMID: 8916146 Ref: Spontaneous apoptosis in gallbladder carcinoma. Relationships with clinicopathologic factors, expression of E-cadherin, bcl-2 protooncogene, and p53 oncosuppressor gene. PMID: 8918403 |
Ref: [Mode of spreading and biological behavior in bile duct carcinoma]. PMID: 9213311 Ref: DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma. PMID: 9232344 Ref: Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma. PMID: 9236898 Ref: A case of equine cholangiocarcinoma displaying aberrant expression of p53 protein. PMID: 9257438 Ref: Immunohistochemical detection of proliferating cell nuclear antigen and p53 expression in carcinoma of the extrahepatic bile duct. PMID: 9260603 Ref: p53 hot-spot mutational analysis in advanced Western gallbladder carcinoma. PMID: 9276709 Ref: [Squamous carcinoma of the gallbladder. Anatomo-clinical study of a case with reference to oncogene expression]. PMID: 9312737 Ref: p53 tumour suppressor gene protein expression in early and advanced gallbladder carcinoma. PMID: 9354892 Ref: TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns. PMID: 9376195 Ref: Surgical strategy for patients with pancreaticobiliary maljunction without choledocal dilatation. PMID: 9444927 Ref: Cancer genes and cholangiocarcinoma. PMID: 9656355 Ref: Radiosensitivity of human biliary tract cancer cell lines in vitro. PMID: 21533411 |
Ref: Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. PMID: 9537436 Ref: Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile. PMID: 9568784 Ref: Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. PMID: 9669809 Ref: A novel TP53 germ-line mutation identified in a girl with a primitive neuroectodermal tumor and her father. PMID: 9723024 Ref: K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients. PMID: 9740272 Ref: [Gene p53 mutations and overexpression of p53 protein in tumors of the Vater's ampulla]. PMID: 9762287 Ref: Mutations of the human MUT S homologue 6 gene in ampullary carcinoma and gastric cancer. PMID: 9808525 Ref: c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma. PMID: 9822921 Ref: Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. PMID: 9828214 Ref: Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder. PMID: 9864969 Ref: [Genetic alterations in gallbladder carcinoma: a review]. PMID: 9866832 |
Ref: Cyclin E overexpression in human gallbladder carcinomas. PMID: 9864408 Ref: Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. PMID: 9923922 Ref: Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis. PMID: 10023698 Ref: Well-differentiated adenocarcinoma, gastric foveolar type, of the extrahepatic bile ducts: A previously unrecognized and distinctive morphologic variant of bile duct carcinoma. PMID: 10196386 Ref: Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma. PMID: 10212000 Ref: Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. PMID: 10362118 Ref: p53 mutations in tumor and non-tumor tissues of thorotrast recipients: a model for cellular selection during radiation carcinogenesis in the liver. PMID: 10383902 Ref: Diagnostic imaging of early gallbladder cancer: retrospective study of 53 cases. PMID: 10390591 Ref: Intrahepatic cholangiocarcinoma in Korea. PMID: 10398901 Ref: Gallbladder carcinoma. PMID: 10436804 Ref: Histological and genetic changes in malignant transformation of gallbladder adenoma. PMID: 10436806 Ref: Biliopancreatic malignancy: screening the at risk patient with molecular markers. PMID: 10436811 Ref: Loss of heterozygosity in dysplasia and carcinoma of the gallbladder. PMID: 10463477 Ref: Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma. PMID: 10469215 Ref: Carcinogenesis in the biliary system associated with APDJ. PMID: 10526055 Ref: Cellular kinetics and gene mutations in gallbladder mucosa with an anomalous junction of pancreaticobiliary duct. PMID: 10526056 Ref: Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma. PMID: 10526058 Ref: Diagnostic p53 immunostaining of endobiliary brush cytology: preoperative cytology compared with the surgical specimen. PMID: 10536357 Ref: Analysis of genetic changes in intrahepatic cholangiocarcinoma induced by thorotrast. PMID: 10564951 Ref: Epithelial hyperplasia of the gallbladder in children with anomalous pancreaticobiliary ductal union. PMID: 10626162 |
Ref: Clinicopathologic correlation of p53 protein overexpression in adenoma and carcinoma of the ampulla of Vater. PMID: 10594204 Ref: Enhanced cell kinetics, p53 accumulation and high p21WAF1 expression in chronic cholecystitis: comparison with background mucosa of gallbladder carcinomas. PMID: 10632753 Ref: Chronic inflammatory bowel disease and cancer. PMID: 10690586 Ref: Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver. PMID: 10711445 Ref: TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas. PMID: 10718212 Ref: Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development. PMID: 10735605 Ref: Aberrations of the K-ras, p53, and APC genes in extrahepatic bile duct cancer. PMID: 10738270 Ref: Overexpression of p53 protein in gallbladder carcinoma in North India. PMID: 10744937 Ref: Increased expression of N-myristoyltransferase in gallbladder carcinomas. PMID: 10813869 Ref: Fas-Fas ligand pathway does not actively work in extrahepatic bile duct carcinoma. PMID: 10928141 Ref: [P53 gene mutation in gallbladder cancer]. PMID: 10962865 Ref: Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological features. PMID: 10963376 Ref: Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers. PMID: 10968854 Ref: Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction. PMID: 10982614 Ref: Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan. PMID: 10982615 Ref: New p53 mutations in hilar cholangiocarcinoma. PMID: 10998080 Ref: Allelic loss in human intrahepatic cholangiocarcinoma: correlation between chromosome 8p22 and tumor progression. PMID: 11004673 Ref: Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors. PMID: 11020850 Ref: [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa]. PMID: 11029885 Ref: Microsatellite instability in gallbladder carcinoma: two independent genetic pathways of gallbladder carcinogenesis. PMID: 11063221 Ref: Genes and viruses in hepatobiliary neoplasia. PMID: 11126384 Ref: Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis. PMID: 11144921 Ref: Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions. PMID: 11144926 Ref: p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer. PMID: 11180865 Ref: Prevalence and clinical relevance of serum anti-p53 antibodies in patients with cholangiocarcinoma. PMID: 11270475 Ref: [P53 tumor suppressor gene in digestive neoplasms]. PMID: 11347516 Ref: [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods]. PMID: 12903495 |
Ref: Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. PMID: 11161385 Ref: Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma. PMID: 11168786 Ref: Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study. PMID: 11260864 Ref: Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma. PMID: 11261824 Ref: Low frequency of p53 and ras mutations in bile of patients with hepato-biliary disease: a prospective study in more than 100 patients. PMID: 11264652 Ref: Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. PMID: 11266517 Ref: Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. PMID: 11283934 Ref: Allelotype analysis of gallbladder carcinoma associated with anomalous junction of pancreaticobiliary duct. PMID: 11311485 Ref: Expression and clinical significance of the G1-S modulators in intrahepatic cholangiocellular carcinoma. PMID: 11340376 Ref: Carcinogenesis of cancer of the papilla and ampulla: pathophysiological facts and molecular biological mechanisms. PMID: 11382316 Ref: Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones. PMID: 11382326 Ref: Significance of contracted cholecystitis lesions as high risk for gallbladder carcinogenesis. PMID: 11410319 Ref: Genetic alterations in gallbladder adenoma, dysplasia and carcinoma. PMID: 11410326 Ref: Atypical bile duct adenoma, clear cell type: a previously undescribed tumor of the liver. PMID: 11420469 Ref: Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas. PMID: 11496329 Ref: Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder. PMID: 11521218 Ref: Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma. PMID: 11580146 Ref: Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer. PMID: 11584965 Ref: Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater. PMID: 11677943 Ref: Genetic alterations involved in the development of gallbladder carcinomas from Greek patients. PMID: 11677947 Ref: Immunohistochemical detection of 8-hydroxy-2'-deoxyguanosine in gallbladder epithelium of patients with pancreaticobiliary maljunction. PMID: 11692064 Ref: Hepatocellular carcinoma: an update. PMID: 11783914 Ref: [Genotyping of multiple genetic alterations of intrahepatic cholangiocarcinoma]. PMID: 11798885 Ref: [Relationship between genetic alterations and clinicopathological features in intrahepatic cholangiocarcinoma]. PMID: 11866974 Ref: Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas. PMID: 12120204 |
Ref: Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines. PMID: 11802210 Ref: Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction. PMID: 11898040 Ref: Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. PMID: 11953819 Ref: Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. PMID: 12000734 Ref: Recent advances in pancreaticobiliary maljunction. PMID: 12021897 Ref: Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma. PMID: 12063950 Ref: Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. PMID: 12094375 Ref: Establishment and characterisation of six human biliary tract cancer cell lines. PMID: 12107841 Ref: Genetic analysis of xanthogranulomatous cholecystitis: precancerous lesion of gallbladder cancer? PMID: 12143246 Ref: Microsatellite alterations in liver fluke related cholangiocarcinoma are associated with poor prognosis. PMID: 12175538 Ref: Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. PMID: 12210082 Ref: Deregulation of G1/S transition is a common event in carcinoma of the ampulla of vater. PMID: 12239913 Ref: K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. PMID: 12374683 Ref: Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. PMID: 12378511 Ref: P53 labeling index in cholangioscopic biopsies is useful for determining spread of bile duct carcinomas. PMID: 12397277 Ref: Treatment of ampullary villous adenomas that may harbor carcinoma. PMID: 12399068 Ref: Biliary papillomatosis arising in a congenital choledochal cyst: report of a case. PMID: 12444445 Ref: Cellular and molecular biology of biliary tract cancers. PMID: 12607585 |
Ref: Genetic abnormalities in pancreatic cancer. PMID: 12537585 Ref: Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. PMID: 12576437 Ref: Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesis. PMID: 12668978 Ref: Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. PMID: 12692194 Ref: Biliary adenofibroma: a rare neoplasm of bile duct origin with an indolent behavior. PMID: 12717255 Ref: Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas. PMID: 12730870 Ref: An autopsy case of gallbladder cancer developing in a Japanese man with cerebrotendinous xanthomatosis: genetic analysis of the sterol 27-hydroxylase and p53 genes. PMID: 12745462 Ref: Extended operation with or without intraoperative (IORT) and external (EBRT) radiotherapy for gallbladder carcinoma. PMID: 12749210 Ref: PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway. PMID: 12829999 Ref: Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma. PMID: 12883663 Ref: Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma. PMID: 12969785 Ref: Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. PMID: 14562286 Ref: Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. PMID: 14598145 Ref: Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas. PMID: 14696408 Ref: Correlated expression of inducible nitric oxide synthase and P53, Bax in benign and malignant diseased gallbladder. PMID: 14704000 Ref: Growth Suppression and Induction of Chemosensitivity in Human Gallbladder Epithelial Carcinoma Cells (GBCE) by Adenovirus-Mediated Transfer of the Wild-type p53 Gene. PMID: 26680985 |
Ref: Anti-p53 antibodies and p53 protein expression in cholangiocarcinoma. PMID: 15011824 Ref: Sarcomatoid carcinoma of common bile duct: a case report. PMID: 15011841 Ref: Antineoplastic effects of octreotide on human gallbladder cancer cells in vitro. PMID: 15052690 Ref: p53 analysis in gallbladder cancer: comparison of gene analysis versus immunohistochemistry. PMID: 15154647 Ref: Gallbladder cancer: current status. PMID: 15163272 Ref: Serum and bile markers for cholangiocarcinoma. PMID: 15192787 Ref: Immunohistochemical study of microvessel density, CD44 (standard form), p53 protein and c-erbB2 in gallbladder carcinoma. PMID: 15209630 Ref: Expression of epidermal growth factor receptor, apomucins, matrix metalloproteinases, and p53 in rat and human cholangiocarcinoma: appraisal of an animal model of cholangiocarcinoma. PMID: 15213623 Ref: Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability. PMID: 15221372 Ref: Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. PMID: 15223956 Ref: Pathologic changes in the non-carcinomatous epithelium of the gallbladder in patients with a relatively long common channel. PMID: 15229426 Ref: The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases. PMID: 15362740 Ref: Cholangiocarcinoma: risk factors, diagnosis and management. PMID: 15529594 Ref: Immunohistochemical analysis of biliary tract lesions. PMID: 15551730 Ref: Immunohistochemical study of characteristics of bile duct dysplasia evaluated on the basis of expression of metastasis/invasion-related factors and p53. PMID: 15619017 Ref: Telomerase activity and Bcl-2 expression in gallbladders of pancreaticobiliary maljunction patients: a preliminary study. PMID: 15754044 Ref: Gallbladder carcinoma: the role of p53 protein overexpression and Ki-67 antigen expression as prognostic markers. PMID: 18333072 |
Ref: An immunohistochemical study of the expression of cell-cycle-regulated proteins p53, cyclin D1, RB, p27, Ki67 and MSH2 in gallbladder carcinoma and its precursor lesions. PMID: 15578423 Ref: Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma. PMID: 15677536 Ref: Aberrant methylation of Reprimo in human malignancies. PMID: 15700311 Ref: Histologic and genetic analysis of the gallbladder in patients with occult pancreatobiliary reflux. PMID: 15702232 Ref: Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation. PMID: 15722574 Ref: [Immunohistochemical study of p53 mutation and p16, p14 alterations encoded by INK4a-ARF in mucin-hypersecreting bile duct tumor]. PMID: 15778546 Ref: Regulators of apoptosis in cholangiocarcinoma. PMID: 15794670 Ref: Mucosa-associated lymphoid tissue lymphoma of the extrahepatic bile duct. PMID: 15816435 Ref: Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers. PMID: 15915369 Ref: p53 Mutations in human cholangiocarcinoma: a review. PMID: 15998419 Ref: Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis. PMID: 16024633 Ref: Prediction of prognosis in gallbladder carcinoma by mucin and p53 immunohistochemistry. PMID: 16114133 Ref: Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions. PMID: 16116640 Ref: TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma. PMID: 16177659 Ref: [Research on resveratrol's effects on suppressing growth and inducing apoptosis of GBC cells]. PMID: 16209266 |
Ref: High-level microsatellite instability is not involved in gallbladder carcinogenesis. PMID: 15963980 Ref: Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma for the determination of tumor vascularity. PMID: 16489641 Ref: Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. PMID: 16505435 Ref: Aberrant p53 expression and the development of gallbladder carcinoma and adenoma. PMID: 16568721 Ref: Analysis of p53 mutations for a mutational signature in human intrahepatic cholangiocarcinoma. PMID: 16596244 Ref: Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes. PMID: 16679351 Ref: Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582. PMID: 16686942 Ref: Infection as a risk factor for gallbladder cancer. PMID: 16724347 Ref: K-ras, p53 mutations, and microsatellite instability (MSI) in gallbladder cancer. PMID: 16724348 Ref: Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions. PMID: 16733863 Ref: Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice. PMID: 16818635 Ref: Double cancer of gall bladder and bile duct not associated with anomalous junction of the pancreaticobiliary duct system. PMID: 16908513 Ref: Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma. PMID: 16937443 Ref: [Frequency of loss of heterozygosity on chromosome 17 in intrahepatic cholangiocarcinoma]. PMID: 17047434 |
Ref: Bile duct cyst as precursor to biliary tract cancer. PMID: 17187167 Ref: Long-term survival after radical resection for pancreatic head and ampullary cancer: a potential role for the EGF-R. PMID: 17369680 Ref: 14-3-3sigma negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma. PMID: 17391729 Ref: Diagnosis and surgical management of gallbladder cancer: a review. PMID: 17468929 Ref: A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma. PMID: 17523309 Ref: Polymorphisms of cytochrome P450 1A1, glutathione S-transferase class mu, and tumour protein p53 genes and the risk of developing gallbladder cancer in Japanese. PMID: 17531965 Ref: Intraductal papillary cholangiocarcinoma and atypical biliary epithelial lesions confused with intrabiliary extension of metastatic colorectal carcinoma. PMID: 17591040 Ref: Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer. PMID: 17595796 Ref: FBXW7/hCDC4 is a general tumor suppressor in human cancer. PMID: 17909001 Ref: Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas. PMID: 18158568 Ref: Immunohistochemical markers in the study of gallbladder premalignant lesions and cancer. PMID: 18293709 |
Ref: [A case of gallbladder adenoma with wide base]. PMID: 18176045 Ref: Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. PMID: 18176964 Ref: Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. PMID: 18306229 Ref: Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases. PMID: 18425077 Ref: Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. PMID: 18495210 Ref: Identical p53 gene mutation in malignant proliferating trichilemmal tumour of the scalp and small cell carcinoma of the common bile duct: the necessity for therapeutic caution? PMID: 18510672 Ref: Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma. PMID: 18677542 Ref: [A pilot experience with a tumor bank]. PMID: 18769829 Ref: Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas. PMID: 18854271 Ref: [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers]. PMID: 18942395 Ref: Effect of genetic predisposition on the risk of gallbladder cancer in Hungary. PMID: 18990008 Ref: Biomarkers in carcinoma of the gallbladder. PMID: 23495740 |
Ref: Prognostic molecular markers in cholangiocarcinoma: a systematic review. PMID: 18938071 Ref: Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer. PMID: 18979138 Ref: Fibroinflammatory biliary stricture: a rare bile duct lesion masquerading as cholangiocarcinoma. PMID: 19057967 Ref: p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction. PMID: 19183832 Ref: Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: correlation with clinicopathologic features and patient survival. PMID: 19190145 Ref: Endocrine cells in ampullary carcinoma. PMID: 19214369 Ref: A comprehensive analysis of immunohistochemical studies in intrahepatic cholangiocarcinoma using the survival tree model. PMID: 19262069 Ref: Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells. PMID: 19287191 Ref: Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models. PMID: 19345377 Ref: Fibroadenoma of the gallbladder with borderline malignancy: a poorly recognized gallbladder tumor. PMID: 19350196 Ref: Antiproliferation and apoptosis induced by tamoxifen in human bile duct carcinoma QBC939 cells via upregulated p53 expression. PMID: 19460356 Ref: IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas. PMID: 19467694 Ref: Cholangiocarcinomas associated with long-term inflammation express the activation-induced cytidine deaminase and germinal center-associated nuclear protein involved in immunoglobulin V-region diversification. PMID: 19578742 Ref: Staining for intracytoplasmic lumina and CAM5.2 increases the detection rate for bile duct cancers. PMID: 19866394 Ref: Correlation of aberrant expression of p53, Rad50, and cyclin-E proteins with microsatellite instability in gallbladder adenocarcinomas. PMID: 19866438 Ref: [p53 and p27 gene expression in subserosal gallbladder carcinoma]. PMID: 19915764 Ref: Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro. PMID: 19950772 Ref: Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts. PMID: 21160963 |
Ref: Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screening. PMID: 19780758 Ref: Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract. PMID: 19819644 Ref: T-cadherin modulates tumor-associated molecules in gallbladder cancer cells. PMID: 20121546 Ref: An update on cholangiocarcinoma associated with primary sclerosing cholangitis. PMID: 20216413 Ref: Surgical treatment of intrahepatic cholangiocarcinoma--a single center experience. PMID: 20420253 Ref: Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis. PMID: 20428886 Ref: Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells. PMID: 20480521 Ref: Redox modulation and human bile duct cancer inhibition by curcumin. PMID: 20510329 Ref: Evidence that genetic variants of metabolic detoxication and cell cycle control are not related to gallbladder cancer risk in Chilean women. PMID: 20544687 Ref: Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. PMID: 20621328 Ref: [Genetic alterations in preneoplastic and neoplastic injuries of the gallbladder]. PMID: 20668816 Ref: Cyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomas. PMID: 20846124 Ref: Alterations of p53 gene in gallbladder cancer patients of North India. PMID: 20862982 Ref: Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis. PMID: 20924037 Ref: p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis. PMID: 20935395 Ref: Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer. PMID: 20955617 Ref: Spindle Cell Carcinoma of the Common Bile Duct: Case Report with Immunohistochemical Analysis. PMID: 21060703 Ref: Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked to gallbladder carcinogenesis. PMID: 21115891 |
Ref: p53 status and its prognostic role in extrahepatic bile duct cancer: a meta-analysis of published studies. PMID: 20668938 Ref: Papillary carcinoma with diffuse papillomatosis of gallbladder and cystic duct. PMID: 20952295 Ref: p53: its alteration and gallbladder cancer. PMID: 21131824 Ref: A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas. PMID: 21292296 Ref: Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction. PMID: 21344355 Ref: Apoptosis of human cholangiocarcinoma cell lines induced by beta-escin through mitochondrial caspase-dependent pathway. PMID: 21394804 Ref: Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. PMID: 21412069 Ref: Xanthogranulomatous cholecystitis: a premalignant condition? PMID: 21459725 Ref: Intrahepatic lymphoepithelioma-like cholangiocarcinoma not associated with epstein-barr virus: a case report. PMID: 21475593 Ref: Genetics of hepatobiliary carcinogenesis. PMID: 21538283 Ref: Cytokeratin 7 and 20 expression in gallbladder carcinoma. PMID: 21574103 Ref: Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. PMID: 21708280 Ref: Synchronous double primary cancers associated with a choledochal cyst and anomalous pancreaticobiliary ductal union. PMID: 22111085 |
Ref: Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss. PMID: 21898503 Ref: Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. PMID: 22180306 Ref: Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma. PMID: 22230750 Ref: Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma. PMID: 22266220 Ref: The value of thioredoxin family proteins and proliferation markers in dysplastic and malignant gallbladders in patients with primary sclerosing cholangitis. PMID: 22370917 Ref: Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE. PMID: 22425181 Ref: Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibility. PMID: 22807971 Ref: Establishment and characterization of a new human gallbladder carcinoma cell line. PMID: 22843894 Ref: Intraductal neoplasm of the intrahepatic bile duct: clinicopathological study of 24 cases. PMID: 22851859 Ref: Non-invasive intraductal papillary neoplasms of the common bile duct: a clinicopathologic study of six cases. PMID: 22977666 Ref: Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma. PMID: 23060400 Ref: Intrahepatic cholangiocarcinoma with predominant "ductal plate malformation" pattern: a new subtype. PMID: 23073321 Ref: Intraductal tubular neoplasms of the bile ducts. PMID: 23073323 Ref: Molecular biology of gallbladder cancer: potential clinical implications. PMID: 23112962 Ref: Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis. PMID: 23298486 |
Ref: Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. PMID: 22824796 Ref: Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma. PMID: 23134201 Ref: Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct. PMID: 23163606 Ref: Adenocarcinoma of gallbladder: an immunohistochemical profile and comparison with cholangiocarcinoma. PMID: 23268317 Ref: p53 and beta-catenin expression in gallbladder tissues and correlation with tumor progression in gallbladder cancer. PMID: 23319036 Ref: KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas. PMID: 23335286 Ref: Ratio disruption of the 133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma. PMID: 23404110 Ref: Histological characteristics of biliary intraepithelial neoplasia-3 and intraepithelial spread of cholangiocarcinoma. PMID: 23446751 Ref: Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype. PMID: 23573322 Ref: ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma. PMID: 23613672 Ref: Tumor-related gene changes in immunosuppressive Syrian hamster cholangiocarcinoma. PMID: 23645518 Ref: Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivo. PMID: 23727990 Ref: An extended fluorescence in situ hybridization approach for the cytogenetic study of cholangiocarcinoma on endoscopic retrograde cholangiopancreatography brushing cytology preparations. PMID: 23845469 Ref: Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer. PMID: 24131658 Ref: Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo. PMID: 24204826 Ref: Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. PMID: 24349281 Ref: Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers. PMID: 24454372 Ref: Mitotic count reflects prognosis of gallbladder cancer particularly among patients with T3 tumor. PMID: 24649220 |
Ref: Curative resection of hilar cholangiocarcinoma in a 25-year-old woman: report of a case. PMID: 23580078 Ref: Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways. PMID: 23828315 Ref: BCL6 overexpression is associated with decreased p19 ARF expression and confers an independent prognosticator in gallbladder carcinoma. PMID: 24114011 Ref: Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: a guide to adjuvant clinical trials. PMID: 24122302 Ref: Expression of cell cycle-related proteins, p16, p53 and p63 as important prognostic markers in gallbladder adenocarcinoma. PMID: 24178677 Ref: High throughput molecular profiling reveals differential mutation patterns in intrahepatic cholangiocarcinomas arising in chronic advanced liver diseases. PMID: 24186137 Ref: Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma. PMID: 24310400 Ref: Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis. PMID: 24329682 Ref: Induction of apoptosis in cholangiocarcinoma by an andrographolide analogue is mediated through topoisomerase II alpha inhibition. PMID: 24360936 Ref: Molecular characterization of gallbladder cancer using somatic mutation profiling. PMID: 24508317 Ref: New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing. PMID: 24563076 Ref: Mutation profiling in gallbladder cancer in Indian population. PMID: 24739824 Ref: UHRF1 depletion suppresses growth of gallbladder cancer cells through induction of apoptosis and cell cycle arrest. PMID: 24756644 Ref: Establishment of a novel cell line from intraductal papillary neoplasm of the bile duct. PMID: 24778022 Ref: Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer. PMID: 24827397 Ref: Histological Characterization of Biliary Intraepithelial Neoplasia with respect to Pancreatic Intraepithelial Neoplasia. PMID: 24860672 Ref: Association between cellular radiosensitivity and G1/G2 checkpoint proficiencies in human cholangiocarcinoma cell lines. PMID: 24969815 Ref: Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. PMID: 24997986 Ref: Evaluation of P53, E-cadherin, Cox-2, and EGFR protein immunoexpression on prognostic of resected gallbladder carcinoma. PMID: 25004291 Ref: Tubulin beta-III: a novel immunohistochemical marker for intrahepatic peripheral cholangiocarcinoma. PMID: 25039376 Ref: High frequency of TP53 but not K-ras gene mutations in Bolivian patients with gallbladder cancer. PMID: 25041017 Ref: MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression. PMID: 25131931 Ref: Different carcinogenic process in cholangiocarcinoma cases epidemically developing among workers of a printing company in Japan. PMID: 25197345 Ref: Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma. PMID: 25225463 Ref: High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma. PMID: 25245603 Ref: Gallbladder cancer: Clinical and pathological approach. PMID: 25325061 Ref: Mutational landscape of intrahepatic cholangiocarcinoma. PMID: 25526346 Ref: Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PMID: 25536104 Ref: [A case of synchronous cancer of the gall bladder, common bile duct, and the papilla of vater]. PMID: 25731239 |
Ref: Surgery for Li Fraumeni syndrome: pushing the limits of surgical oncology. PMID: 23563208 Ref: Deregulation of MYC and TP53 through genetic and epigenetic alterations in gallbladder carcinomas. PMID: 25200035 Ref: Molecular diagnosis of intrahepatic cholangiocarcinoma. PMID: 25267595 Ref: Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness. PMID: 25367684 Ref: Autophagy may occur at an early stage of cholangiocarcinogenesis via biliary intraepithelial neoplasia. PMID: 25466963 Ref: An immunohistochemical marker panel including claudin-18, maspin, and p53 improves diagnostic accuracy of bile duct neoplasms in surgical and presurgical biopsy specimens. PMID: 25503275 Ref: Microsatellite instability in gallbladder carcinoma. PMID: 25680569 Ref: Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases. PMID: 26111977 Ref: Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing. PMID: 26189129 Ref: Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes. PMID: 26207380 Ref: Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway. PMID: 26250568 Ref: Cholangiocarcinoma: from molecular biology to treatment. PMID: 26427701 Ref: Anticancer bioactive peptides suppress human colorectal tumor cell growth and induce apoptosis via modulating the PARP-p53-Mcl-1 signaling pathway. PMID: 26592508 Ref: High DBC1 (CCAR2) expression in gallbladder carcinoma is associated with favorable clinicopathological factors. PMID: 26617872 Ref: A case study of a collision tumor composed of cancers of the bile duct and pancreas. PMID: 26943405 |
Ref: Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient. PMID: 26486326 Ref: Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients. PMID: 26717940 Ref: Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions. PMID: 26729014 Ref: Galectin-9: An anticancer molecule for gallbladder carcinoma. PMID: 26797414 Ref: Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma. PMID: 26806338 Ref: Cystic micropapillary neoplasm of peribiliary glands with concomitant perihilar cholangiocarcinoma. PMID: 26900302 Ref: CYP1A1, GSTM1, GSTT1 and TP53 Polymorphisms and Risk of Gallbladder Cancer in Bolivians. PMID: 26925680 Ref: Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression. PMID: 26935396 Ref: The inflammatory inception of gallbladder cancer. PMID: 26980625 Ref: Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations. PMID: 27009864 Ref: Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing. PMID: 27267833 Ref: High expression of karyopherin-alpha2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction. PMID: 27338241 Ref: Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo. PMID: 27349455 Ref: Proliferative index facilitates distinction between benign biliary lesions and intrahepatic cholangiocarcinoma. PMID: 27396933 Ref: Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression. PMID: 27472451 Ref: TAZ regulates cell proliferation and sensitivity to vitamin D3 in intrahepatic cholangiocarcinoma. PMID: 27554639 Ref: Biliary cancer: Utility of next-generation sequencing for clinical management. PMID: 27622582 Ref: Report of a case with gallbladder carcinoma: P53 expression of the peritumor epithelium might predict biliary tract recurrence. PMID: 27776323 Ref: Prognostic Significance of HER-2 and p53 Expression in Gallbladder Carcinoma in North Indian Patients. PMID: 27784017 Ref: Molecular characteristics of biliary tract cancer. PMID: 27823638 Ref: Gallbladder cancer: South American experience. PMID: 27829280 Ref: KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract Cancers. PMID: 28008299 |
Ref: Elevated DeltaNp63alpha Levels Facilitate Epidermal and Biliary Oncogenic Transformation. PMID: 27725202 Ref: Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing. PMID: 28029662 Ref: Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity. PMID: 28126467 Ref: JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling. PMID: 28337870 Ref: Association of Aflatoxin and Gallbladder Cancer. PMID: 28428144 Ref: Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS. PMID: 28609656 Ref: Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma. PMID: 28648284 Ref: Genetic alterations in Japanese extrahepatic biliary tract cancer. PMID: 28693246 Ref: Adenosquamous gallbladder carcinoma: Multigene hotspot mutational profiling reveals a monoclonal origin of the two components. PMID: 28698100 Ref: Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway. PMID: 28913568 Ref: Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand. PMID: 29110582 |
Ref: Clinicopathologic Study of Biliary Intraepithelial Neoplasia in Cholangiocarcinoma. PMID: 28490009 Ref: Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma. PMID: 29278425 Ref: MDM2 Amplification in Intrahepatic Cholangiocarcinomas: Its Relationship With Large-Duct Type Morphology and Uncommon KRAS Mutations. PMID: 29309301 Ref: Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer. PMID: 29334603 Ref: Primary Liver Cancers, Part 2: Progression Pathways and Carcinogenesis. PMID: 29353494 Ref: Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. PMID: 29360550 Ref: Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity. PMID: 29408647 Ref: PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study. PMID: 29413685 Ref: Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers. PMID: 29416916 Ref: Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma. PMID: 29551704 Ref: Molecular genomic landscapes of hepatobiliary cancer. PMID: 29573058 Ref: Mucinous intrahepatic cholangiocarcinoma: a distinct variant. PMID: 29698701 Ref: MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions. PMID: 29731265 Ref: Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma. PMID: 29740198 Ref: Ampullary carcinoma-A genetic perspective. PMID: 29807574 Ref: Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention. PMID: 29848569 Ref: Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma. PMID: 29871934 Ref: ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass. PMID: 30006612 Ref: Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type. PMID: 30158952 Ref: Clinical significance of interleukin-6 in diagnosis of lung, oral, esophageal, and gall bladder carcinomas. PMID: 30249899 |